Daniel B. Rukstalis, M.D.
Academic: 336-716-0287 | Department: 336-716-4131
Roehrborn C, Gange S, Shore N, Giddens J, Bolton D, Cowan B, Mcvary K, Chin P, Rashid P, Rukstalis D. Prospective, randomised, blinded study of Prostatic Urethral Lift (PUL): four year results [abstract]. BJU Int. 2016;117(Suppl 3):19-20.
Baust JG, Bischof JC, Jiang-Hughes S, Polascik TJ, Rukstalis DB, Gage AA, Baust JM. Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue. Prostate Cancer Prostatic Dis. 2015;18(2):87-95.
Rashid P, Chin P, Bolton D, Rukstalis D, Giddens J, Gange S, Shore N, Cowan B, Brown BT, McVary K, Te A, Gholami S, Moseley W, Tutrone R, Freedman S, Incze P, Coffield KS, Borges F, Roehrborn C. Prospective, randomised study of Prostatic Urethral Lift (PUL) with three year results [abstract]. BJU Int. 2015;115(Suppl 4):10-11.
Butcher MJ, Roehrborn CC, Gange SN, Bolton DM, Te AE, Shore ND, Chin PT, Rashid P, Rukstalis DB, McVary KT. Impact on sexual function and two year durability of the prostatic urethral lift: a multi-center, prospective, randomized study [abstract]. J Sex Med. 2015;12(Suppl 2):101.
Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rashid P. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol. 2015;22(3):7772-7782.
Rukstalis DB. Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man. Can J Urol. 2015;22(5 Suppl 1):67-74.
Rukstalis DB. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney [editorial comment]. Urology. 2014;83(2):362.
Rukstalis DB. Pelvic ultrasound evaluation for benign prostatic hyperplasia: prediction of obstruction. Curr Urol Rep. 2014;15(5):403.
McVary K, Gange S, Shore N, Giddens J, Bolton D, Brown BT, Te A, Chin P, Rukstalis D, Roehrborn C. Treatment of luts secondary to Bph while preserving sexual function: randomized controlled study of prostatic urethral lift [abstract]. J Sex Med. 2014;11(Suppl 3):174.
Mcvary KT, Gange SN, Shore ND, Bolton DM, Cowan BE, Brown BT, Te AE, Chin PT, Rukstalis DB, Roehrborn CG. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med. 2014;11(1):279-287.
Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013;190(6):2161-2167.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.